Jazz Pharmaceuticals
JAZZ
JAZZ
570 hedge funds and large institutions have $10.5B invested in Jazz Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 128 funds opening new positions, 179 increasing their positions, 192 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 500 → 570 (+70)
1.41% more ownership
Funds ownership: 99.98% → 101.39% (+1.4%)
7% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 192
Holders
570
Holding in Top 10
15
Calls
$172M
Puts
$50.2M
Top Buyers
| 1 | +$173M | |
| 2 | +$143M | |
| 3 | +$110M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$68.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$60.6M |
Top Sellers
| 1 | -$126M | |
| 2 | -$110M | |
| 3 | -$87.8M | |
| 4 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
-$68.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$59M |
